CIK 0001541157
- Non-accelerated filer
- Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- EIN
- 981034922
- Phone
- +1 929-274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 8-K/A Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Executive or director change
- 8-K Event Executive or director change · Other events
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Shareholder vote results · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
Page 3 of 4 · 79 filings